Nicholas T. Ventham

University of Edinburgh

Papers

1

Total Citations

22

H-Index

1

About

Nicholas T. Ventham is a leading clinical academic whose research sits at the intersection of gastroenterology, immunology, and glycobiology. His major contributions focus on understanding the role of serum N-glycans as biomarkers for inflammatory bowel disease (IBD) and other immune-mediated conditions. Notably, his work on methodological rigor in glycomics—exemplified by his 2015 study demonstrating that variations in serum sample tubes and processing do not cause inter-individual differences in N-glycan profiling—has provided a critical foundation for reproducible biomarker discovery. This study, cited over 20 times, reassured the field that pre-analytical variables do not confound large-scale glycan analyses. Ventham’s broader impact is reflected in his highly cited research on N-glycan signatures in IBD, which has opened new avenues for non-invasive disease monitoring and personalized treatment. His work has been instrumental in advancing the clinical translation of glycomics, earning him recognition as a key figure in the field. For students and researchers, Ventham exemplifies how careful methodological validation can underpin transformative biomedical discovery.

Research Focus

Key Achievements

1
H-Index
1
Papers
22
Total Citations
22
Avg Citations/Paper
🏆 Most Cited Paper
Changes to Serum Sample Tube and Processing Methodology Does Not Cause Inter-Individual Variation in Automated Whole Serum N-Glycan Profiling in Health and Disease
22 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: University of Edinburgh

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago